We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

This study has been terminated.
(Interim analysis did not show good results for main objective)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01104298
First Posted: April 15, 2010
Last Update Posted: October 27, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Grupo Espanol de Investigacion en Sarcomas
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2014
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)